GlassScriptPhysician profile
Sona Ramdath
NPI 1699923060
$1,128.62
in general payments reported to CMS, 2019-2025
18 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.86 · 2020: $192 · 2021: $131 · 2022: $203 · 2023: $202 · 2024: $173 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $212.88 | 2019-2022 | |
| Linvatec Corporation | $154.78 | 2024 | Biobrace 23mm |
| Angiodynamics, INC. | $133.47 | 2022 | |
| Smith+Nephew, INC. | $133.20 | 2019-2024 | Stravix Pl, Renasys Go V2 Home |
| Orthofix Medical, INC. | $126.69 | 2025 | Truelok |
| Stryker Corporation | $107.93 | 2020-2023 | Phalinx |
| Bioventus LLC | $39.23 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Next Science LLC | $36.10 | 2023 | Xperience, Blastx, Surgx |
| Lifenet Health | $27.77 | 2023 | |
| Treace Medical Concepts, INC. | $26.44 | 2023 | |
| Kerecis Limited | $24.48 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.74 | 2025 | Jublia |
| Pacira Pharmaceuticals Incorporated | $19.92 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.89 | 2023 | Nuzyra |
| In2bones USA, LLC | $13.60 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $13.17 | 2020 | |
| Zyla Life Sciences, INC. | $11.52 | 2020 | |
| Embody, INC. | $10.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sona Ramdath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.